drugset / Trial / NCT00003936
Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of bryostatin 1 in treating patients who have recurrent or refractory Hodgkin's disease.
Timeline
- Start
- 1999-06
- Primary completion
- 2004-06
- Completion
- 2004-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | bryostatin 1 | Small molecule | — | Intravenous |